Table 2 Changes between measurements made before and after the intervention
The TTM group | The other occupational therapy group | Comparisons of changes between groups | |||||||
|---|---|---|---|---|---|---|---|---|---|
Baseline Median (IQR) | After completing the intervention Median (IQR) | Change Median (IQR) | p-value | Baseline Median (IQR) | After completing the intervention Median (IQR) | Change Median (IQR) | P-value | p-value | |
Primary outcomes | |||||||||
COPM | |||||||||
Performance | 4(3, 5) | 5 (3, 6) | 0 (0,1) | ≤ .01 | 3 (3,5) | 5 (3,6) | 0 (1,2) | ≤ .01 | .60 |
Satisfaction | 2 (2, 4) | 4 (2, 6) | 1 (0, 2) | ≤ .01 | 3 (2, 4) | 5 (3, 6) | 1 (0, 2) | ≤ .01 | .59 |
SDO | |||||||||
Activity level | 7 (6, 8) | 7 (6, 9) | 0 (−1, 1) | ≤ .01 | 8 (6, 9) | 8 (6, 10) | 0 (−1, 2) | ≤ .01 | .65 |
Satisfaction score | 63 (50, 76) | 65 (53, 77) | 3 (− 8, 11) | .21 | 62 (53, 69) | 64 (57, 72) | 5 (−5, 11) | .02 | .34 |
OBQ | 23 (17, 30) | 30 (21, 38) | 5 (0, 12) | ≤ .01 | 22 (15, 30) | 30 (21, 37) | 6 (2, 9) | ≤ .01 | 1.00 |
SCL-90-R symptom scales | |||||||||
Depression | 83 (71, 91) | 73 (58, 87) | −8 (−13, 2) | ≤ .01 | 81 (70, 91) | 71 (57, 90) | −2 (−15, 3) | ≤ .01 | .34 |
Anxiety | 81(68, 93) | 71 (53, 91) | −7 (−14, 4) | ≤ .01 | 82 (67, 100) | 78 (61, 93) | −7 (−16, 5) | .01 | .73 |
SCL-90-R indexes | |||||||||
GSI | 81 (69, 96) | 72 (59, 89) | −6 (− 14, 2) | ≤ .01 | 79 (68, 95) | 73 (58, 90) | −4 (−13, 2) | ≤ .01 | .74 |
Positive symptoms | 71 (65, 86) | 65 (56, 78) | ≤ .01 | 70 (63, 77) | 67 (55, 74) | ≤ .01 | .11 | ||
Positive symptoms total | 70 (63, 76) | 66 (56, 76) | .01 | 72 (65, 79) | 69 (61, 76) | ≤ .01 | .27 | ||
MADRS-S | 25 (20, 30) | 20 (11, 29) | −3 (−8, 1) | ≤ .01 | 25 (20, 32) | 20 (14, 27) | −4 (−10, 0) | ≤ .01 | .46 |
HADS | |||||||||
HADS-A | 14 (10, 17) | 12 (8, 15) | −2 (−5, 1) | ≤ .01 | 14 (11, 16) | 12 (9, 15) | −1 (−4, 1) | ≤ .01 | .63 |
HADS-D | 10 (7, 13) | 8 (3, 12) | −2 (−4, 0) | ≤ .01 | 10 (7, 14) | 7 (5, 11) | −2 (−4, 0) | ≤ .01 | 1.00 |
Secondary outcomes | |||||||||
SOC | 47 (39, 55) | 50 (44, 62) | 5 (−1, 11) | ≤ .01 | 46 (41, 57) | 52 (46, 59) | 2 (−4, 9) | .04 | .23 |
Mastery | 18 (16, 20) | 18 (16, 22) | 0 (−1, 2) | .03 | 17 (16, 19) | 18 (16, 21) | 1 (−2, 3) | .09 | .94 |
MANSA | 47 (37, 52) | 50 (38, 61) | 2 (−2, 6) | .02 | 45 (35, 52) | 50 (39, 55) | 3 (−1, 8) | .01 | .75 |
HAq-II | |||||||||
HAq-II OTs’ | 86 (80, 92) | 96 (90, 106) | 11 (7, 16) | ≤ .01 | 85 (80, 90) | 94 (90, 102) | 9 (6, 15) | ≤ .01 | .27 |
HAq-II patients’ | 99 (93, 105) | 106 (99, 111) | 4 (−1, 10) | ≤ .01 | 95 (91, 101) | 102 (94, 107) | 4 (0, 11) | ≤ .01 | .99 |
CSQ | 26 (23, 30) | 26 (24, 30) | .96 | ||||||